The expression of transforming growth factor-?1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma
- 15 October 1999
- Vol. 86 (8) , 1455-1462
- https://doi.org/10.1002/(sici)1097-0142(19991015)86:8<1455::aid-cncr11>3.0.co;2-l
Abstract
Transforming growth factors β (TGFs β) are involved in a variety of important cellular functions, including cell growth and differentiation, adhesion, migration, extracellular matrix formation, and immune function. Moreover, it has been reported that TGFs β are correlated with angiogenesis. However, the role of TGF-β as an angiogenic factor in gastric carcinoma is still unclear. TGF-β1 expression was determined in 101 patients with gastric carcinoma by immunohistochemical procedures, and this expression was compared in the current study with both the expression of vascular endothelial growth factor (VEGF), which is thought to be the most potent angiogenic factor, and microvessel density, to evaluate the effect of TGF-β1 on the angiogenesis of gastric carcinoma tissues. TGF-β1 expression was detected in 23 tumors (22.8%). TGF-β1 expression was more frequent in differentiated than in undifferentiated gastric carcinoma. Furthermore, TGF-β1 expression was significantly correlated with the depth of invasion and the stage of disease. There was a close correlation between TGF-β1 expression and VEGF expression. There was no correlation between TGF-β1 expression and microvessel density, whereas VEGF expression was significantly correlated with microvessel density. With regard to prognosis, the 5-year survival rate was 55.9% for patients with TGF-β1 positive tumors and 67.0% in patients with TGF-β1 negative tumors. Accordingly, the prognosis for patients with TGF-β1 negative tumors was significantly better than that for patients with TGF-β1 positive tumors. Multivariate analysis indicated that lymph node metastasis, tumor size, and TGF-β1 expression were independent prognostic factors. These results suggest that TGF-β1 might be associated with tumor progression by indirectly stimulating angiogenesis through the up-regulation of VEGF expression in gastric carcinoma. Cancer 1999;86:1455–62. © 1999 American Cancer Society.Keywords
This publication has 34 references indexed in Scilit:
- Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinomaSurgery, 1999
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stabilityFEBS Letters, 1995
- Expression of basic fibroblast growth factor in human gastric carcinomasVirchows Archiv B Cell Pathology Including Molecular Pathology, 1992
- Transforming growth factor-beta: recent progress and new challenges.The Journal of cell biology, 1992
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cellsBiochemical and Biophysical Research Communications, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Immunocytochemically Detectable TGF-β Associated with Malignancy in Thyroid Epithelial NeoplasiaGrowth Factors, 1990